Jusletter IT

This article proposes a summary of an intellectual property framework for trans-European medical research projects aiming at answering two important issues at stake: 1) which intellectual property rights arise during the course of such projects, and; 2) which patient rights must be taken into account. The article contains a short analysis of the legal findings of the project ACGT (Advancing Clinico-Genomic Trials on Cancer, www.eu-acgt.org), a European Integrated Project funded by the European Union.